highly significantP = 0.008
The presence of aggregates at baseline was a highly significant predictor of the clinical response to anti-TNF treatment ( P = 0.008), demonstrating that RA patients with synovial lymphocyte aggregates may have a better response to Infliximab treatment than those with only diffuse leucocyte infiltration [ 59 ].